CSL Behring

CSL Behring, headquartered in King of Prussia, PA, USA, is a global leader in the plasma protein biotherapeutics industry. The company manufactures and markets a range of safe, effective plasma-derived and recombinant products. With more than 800 people at its Berne site, CSL Behring AG develops and manufactures plasma products for international markets, and is the Center of Excellence for Immunoglobulins of the CSL Behring Group. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters in Melbourne, Australia.

„At the Berne site we very much appreciate the good cooperation with the authorities, the community and cluster organisations. A high educational background, a stable personnel situation, multilingual skills of many employees, our site in a university town - all these things contribute to making Berne attractive on a global level. And of course the geographic position in the heart of Europe is a positive asset."

Uwe E. Jocham
Senior Vice President and General Manager CSL Behring AG, Berne